Results 171 to 180 of about 2,585,234 (304)

Supplementary Material for: Inflammatory bowel disease burden in Six Different Dietary Regions and Worldwide

figshare admin karger, Ren K., Cong Y., Jin Y., Zhou T., Pan X., Cao B., Ren L., Chen L., Wei H.   +9 more
openalex   +1 more source

Economic Burden of Rare Diseases With Common Diseases as a Comorbidity in Poland

, 2020
Joanna Leśniowska
openalex   +1 more source

Burden of disease of dietary exposure to acrylamide in Denmark [PDF]

, 2016
Granby, Kit, Jakobsen, Lea Sletting, Knudsen, Vibeke Kildegaard, Nauta, Maarten, Pires, Sara Monteiro, Poulsen, Morten   +5 more
core   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

Molecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdry, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Liudmyla Drobot, Petr Beneš, Lucia Knopfová   +10 more
wiley   +1 more source

Correction: Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis [PDF]

Mena Scavina, Nate Posner, Patricia Dorling, A.K. Talaga, Anna Stachel, José Alvir   +5 more
openalex   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Mortality rates in patients with Parkinson's disease: An analysis of the Global Burden of Disease database. [PDF]

Surg Neurol Int
Gould J, Patel S, Chaurasia B.
europepmc   +1 more source

PM2.5-associated burden of disease and its cost in 429 Iranian counties from 2016 to 2018

, 2021
Sasan Faridi, Reza Bayat, Ensieh Sharafkhani, Sadegh Niazi, Heresh Amini, Mohammad Sadegh Hassanvand   +5 more
openalex   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Global and regional disparities in the burden of disease and risk factors between pancreatitis and pancreatic cancer: a systematic analysis for the global burden of disease study. [PDF]

BMC Gastroenterol
Getu MA, Liu J, Ma L, Zhang X.
europepmc   +1 more source